NDC properties for "Synera (lidocaine 70 MG / tetracaine 70 MG) Medicated Patch" (RxCUI 644290)
About this data
The tables show NDC propoerties for Synera (lidocaine 70 MG / tetracaine 70 MG) Medicated Patch with the RxCUI 644290
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Synera (lidocaine 70 MG / tetracaine 70 MG) Medicated Patch (RxCUI 644290)
MMSL_CODE | BD14979 |
---|---|
RxCUI | 644290 |
Prescribable Synonym | Synera 70 MG / 70 MG Medicated Patch |
RXNAV_STR | Synera (lidocaine 70 MG / tetracaine 70 MG) Medicated Patch |
RxNorm Name | lidocaine 70 MG / tetracaine 70 MG Medicated Patch [Synera] |
RxNorm Synonym | Synera (lidocaine 70 MG / tetracaine 70 MG) Medicated Patch |
Related queries | Interactions (for RxCUI 644290) |
NDC Properties
NDC Item 10885000201
NDC 9 | 10885-002 |
---|---|
NDC 10 | 10885-002-01 |
NDC Item | 10885000201 |
Packaging | 1 PATCH in 1 POUCH (10885-002-01) |
FDA SPL set id | 531329 |
Labeler | Galen US Incorporated |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2023-09-30 |
Marketing effective time low | 2013-12-01 |
Marketing status | COMPLETED |
NDA | NDA021623 |
Related queries | Properties for NDC 9 10885-002 |
NDC Item 10885000210
NDC 9 | 10885-002 |
---|---|
NDC 10 | 10885-002-10 |
NDC Item | 10885000210 |
Packaging | 10 PATCH in 1 CARTON (10885-002-10) |
FDA SPL set id | 531329 |
Labeler | Galen US Incorporated |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2023-09-30 |
Marketing effective time low | 2013-12-01 |
Marketing status | COMPLETED |
NDA | NDA021623 |
Related queries | Properties for NDC 9 10885-002 |
NDC Item 43469086401
NDC 9 | 43469-864 |
---|---|
NDC 10 | 43469-864-01 |
NDC Item | 43469086401 |
Packaging | 1 PATCH in 1 POUCH (43469-864-01) |
FDA SPL set id | 63000 |
Labeler | ZARS Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2015-03-31 |
Marketing effective time low | 2005-06-23 |
Marketing status | COMPLETED |
NDA | NDA021623 |
Related queries | Properties for NDC 9 43469-864 |
NDC Item 43469086410
NDC 9 | 43469-864 |
---|---|
NDC 10 | 43469-864-10 |
NDC Item | 43469086410 |
Packaging | 10 PATCH in 1 CARTON (43469-864-10) |
FDA SPL set id | 63000 |
Labeler | ZARS Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2015-03-31 |
Marketing effective time low | 2005-06-23 |
Marketing status | COMPLETED |
NDA | NDA021623 |
Related queries | Properties for NDC 9 43469-864 |
NDC Item 10885000201
NDC 9 | 10885-002 |
---|---|
NDC 10 | 10885-002-01 |
NDC Item | 10885000201 |
Packaging | 1 PATCH in 1 POUCH (10885-002-01) |
FDA SPL set id | 531329 |
Labeler | Galen US Incorporated |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2023-09-30 |
Marketing effective time low | 2013-12-01 |
Marketing status | COMPLETED |
NDA | NDA021623 |
Related queries | Properties for NDC 9 10885-002 |
NDC Item 10885000210
NDC 9 | 10885-002 |
---|---|
NDC 10 | 10885-002-10 |
NDC Item | 10885000210 |
Packaging | 10 PATCH in 1 CARTON (10885-002-10) |
FDA SPL set id | 531329 |
Labeler | Galen US Incorporated |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2023-09-30 |
Marketing effective time low | 2013-12-01 |
Marketing status | COMPLETED |
NDA | NDA021623 |
Related queries | Properties for NDC 9 10885-002 |
NDC Item 43469086401
NDC 9 | 43469-864 |
---|---|
NDC 10 | 43469-864-01 |
NDC Item | 43469086401 |
Packaging | 1 PATCH in 1 POUCH (43469-864-01) |
FDA SPL set id | 63000 |
Labeler | ZARS Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2015-03-31 |
Marketing effective time low | 2005-06-23 |
Marketing status | COMPLETED |
NDA | NDA021623 |
Related queries | Properties for NDC 9 43469-864 |
NDC Item 43469086410
NDC 9 | 43469-864 |
---|---|
NDC 10 | 43469-864-10 |
NDC Item | 43469086410 |
Packaging | 10 PATCH in 1 CARTON (43469-864-10) |
FDA SPL set id | 63000 |
Labeler | ZARS Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2015-03-31 |
Marketing effective time low | 2005-06-23 |
Marketing status | COMPLETED |
NDA | NDA021623 |
Related queries | Properties for NDC 9 43469-864 |
NDC Item 10885000201
NDC 9 | 10885-002 |
---|---|
NDC 10 | 10885-002-01 |
NDC Item | 10885000201 |
Packaging | 1 PATCH in 1 POUCH (10885-002-01) |
FDA SPL set id | 531329 |
Labeler | Galen US Incorporated |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2023-09-30 |
Marketing effective time low | 2013-12-01 |
Marketing status | COMPLETED |
NDA | NDA021623 |
Related queries | Properties for NDC 9 10885-002 |
NDC Item 10885000210
NDC 9 | 10885-002 |
---|---|
NDC 10 | 10885-002-10 |
NDC Item | 10885000210 |
Packaging | 10 PATCH in 1 CARTON (10885-002-10) |
FDA SPL set id | 531329 |
Labeler | Galen US Incorporated |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2023-09-30 |
Marketing effective time low | 2013-12-01 |
Marketing status | COMPLETED |
NDA | NDA021623 |
Related queries | Properties for NDC 9 10885-002 |
NDC Item 43469086401
NDC 9 | 43469-864 |
---|---|
NDC 10 | 43469-864-01 |
NDC Item | 43469086401 |
Packaging | 1 PATCH in 1 POUCH (43469-864-01) |
FDA SPL set id | 63000 |
Labeler | ZARS Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2015-03-31 |
Marketing effective time low | 2005-06-23 |
Marketing status | COMPLETED |
NDA | NDA021623 |
Related queries | Properties for NDC 9 43469-864 |
NDC Item 43469086410
NDC 9 | 43469-864 |
---|---|
NDC 10 | 43469-864-10 |
NDC Item | 43469086410 |
Packaging | 10 PATCH in 1 CARTON (43469-864-10) |
FDA SPL set id | 63000 |
Labeler | ZARS Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2015-03-31 |
Marketing effective time low | 2005-06-23 |
Marketing status | COMPLETED |
NDA | NDA021623 |
Related queries | Properties for NDC 9 43469-864 |
NDC Item 10885000201
NDC 9 | 10885-002 |
---|---|
NDC 10 | 10885-002-01 |
NDC Item | 10885000201 |
Packaging | 1 PATCH in 1 POUCH (10885-002-01) |
FDA SPL set id | 531329 |
Labeler | Galen US Incorporated |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2023-09-30 |
Marketing effective time low | 2013-12-01 |
Marketing status | COMPLETED |
NDA | NDA021623 |
Related queries | Properties for NDC 9 10885-002 |
NDC Item 10885000210
NDC 9 | 10885-002 |
---|---|
NDC 10 | 10885-002-10 |
NDC Item | 10885000210 |
Packaging | 10 PATCH in 1 CARTON (10885-002-10) |
FDA SPL set id | 531329 |
Labeler | Galen US Incorporated |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2023-09-30 |
Marketing effective time low | 2013-12-01 |
Marketing status | COMPLETED |
NDA | NDA021623 |
Related queries | Properties for NDC 9 10885-002 |
NDC Item 43469086401
NDC 9 | 43469-864 |
---|---|
NDC 10 | 43469-864-01 |
NDC Item | 43469086401 |
Packaging | 1 PATCH in 1 POUCH (43469-864-01) |
FDA SPL set id | 63000 |
Labeler | ZARS Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2015-03-31 |
Marketing effective time low | 2005-06-23 |
Marketing status | COMPLETED |
NDA | NDA021623 |
Related queries | Properties for NDC 9 43469-864 |
NDC Item 43469086410
NDC 9 | 43469-864 |
---|---|
NDC 10 | 43469-864-10 |
NDC Item | 43469086410 |
Packaging | 10 PATCH in 1 CARTON (43469-864-10) |
FDA SPL set id | 63000 |
Labeler | ZARS Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2015-03-31 |
Marketing effective time low | 2005-06-23 |
Marketing status | COMPLETED |
NDA | NDA021623 |
Related queries | Properties for NDC 9 43469-864 |